The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / October / 44,000 Protein Forms Mapped in Plasma
Mass Spectrometry Proteomics News and Research

44,000 Protein Forms Mapped in Plasma

DIA mass spectrometry maps extensive proteoform diversity in human plasma

10/19/2026 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll

Share

Clinical Scorecard: 44,000 Protein Forms Mapped in Plasma

At a Glance

CategoryDetail
ConditionHuman plasma proteoform diversity
Key MechanismsProteoforms arise through processes including alternative splicing, protein cleavage, and post-production chemical modifications.
Target PopulationHuman plasma samples analyzed in a proteomics study; the article does not specify a clinical patient population.
Care SettingLaboratory proteomics and biomarker research using plasma samples.

Key Highlights

  • The workflow detected 179,049 potential proteoforms across 5,077 protein groups; 44,083 proteoforms from 2,089 groups met the study’s high-confidence criterion.
  • High-confidence proteoforms were detected in at least three of four replicate gel experiments; the median was 11 per protein.
  • Proteoform diversity was greatest among abundant proteins and proteins involved in nutrient transport, blood clotting, and the complement immune system.
  • Agreement between Olink and SomaScan measurements was generally closer for relatively abundant proteins with low or moderate proteoform diversity.
  • The atlas is an initial reference: most proteoforms were not fully identified at the molecular level, and low-abundance or disease-associated forms may be underrepresented.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

        • Affinity-based assays designed to measure the same protein may recognize different proteoforms, affecting comparisons between technologies and interpretation of results.
        • Poor agreement between Olink and SomaScan was most often associated with low protein concentrations; high proteoform diversity may explain some discrepancies involving more abundant proteins.
        • The analysis may include proteins introduced through cellular contamination, and some findings may represent groups of closely related proteoforms rather than individual molecules.

        Patient & Prescribing Data

        No treatment or prescribing population is described; the study analyzed human plasma proteomes.

        The article reports no treatments or prescribing data. It notes that proteoform differences may affect biomarker assay comparisons and interpretation.

        Clinical Best Practices

        • When comparing affinity-based proteomic measurements, account for the possibility that assays targeting the same protein may recognize different proteoforms.
        • Interpret the atlas as an initial reference rather than a complete account of the plasma proteome.
        • The researchers state that further studies using top-down mass spectrometry, clinical cohorts, and samples from different populations are needed to assess proteoform associations with normal biology and disease.

        Related Resources & Content

        • Article: 44,000 Protein Forms Mapped in Plasma

        This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

        Newsletters

        Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

        Newsletter Signup Image

        False

        Advertisement

        Recommended

        False

        Related Content

         This Week’s Mass Spec News
        Mass Spectrometry
        This Week’s Mass Spec News

        April 4, 2025

        2 min read

         What If Computers Could Smell?
        Mass Spectrometry
        What If Computers Could Smell?

        April 3, 2025

        13 min read

        Computers can “see” and “hear,” but fully digitizing scent has so far eluded science – but that may soon change

        The Analytical Scientist Innovation Awards 2024: #6
        Mass Spectrometry
        The Analytical Scientist Innovation Awards 2024: #6

        December 3, 2024

        3 min read

        Syft Technologies’ William Pelet introduces the Syft Explorer – the world's first fully mobile, real-time, and direct trace gas analyzer

        The Analytical Scientist Innovation Awards 2024: #4
        Mass Spectrometry
        The Analytical Scientist Innovation Awards 2024: #4

        December 5, 2024

        6 min read

        Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

        Affiliations:

        Specialties:

        Areas of Expertise:

        Contributions:

        False

        The Analytical Scientist
        Subscribe

        About

        • About Us
        • Work at Conexiant Europe
        • Terms and Conditions
        • Privacy Policy
        • Your Privacy Choices
        • Advertise With Us
        • Contact Us

        Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.